biotech
Bio-AnalystSupplement research
person

Bacopa

Selected research topic

Digestion and gut health

Some measured outcomes worsened in human comparison studies. The populations and conditions matter.

Publications for this topic
1
Human comparison publications
1
Publications needing review
0

Findings in the studies

  • digestive complaints

    • A worse result than the comparison group was reported.
      General population · Single ingredient · 12 weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · General population
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: 300 mg/day Bacopa monnieri extract versus placebo
      Additional measurement information
      Secondary outcome
      Measurement time
      12 weeks
Representative outcome and study details

Human studies reported between-group worsening in digestive complaints.

Single-ingredient studies · Human studies · between-group comparison

1 publications linked to this result

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 60.3 evidence score includes 12 independent human studies and 11 clinical studies in the representative benefit area. The B tier reflects evidence directness, repetition, and consistency together.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 72

Papers linked to this topic 1 · distinct papers 1 · papers with a confirmed human comparison 1 · papers needing additional review 0

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • digestive complaints: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1

What the research found

digestive complaints

The study reported worsening in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No reviewed caution rules are available yet. Reported caution findings are shown below.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

Rey Auditory Verbal Learning Test (AVLT)1 papers
In a double-blind, placebo-controlled RCT, 300 mg/day Bacopa monnieri significantly improved verbal learning and memory acquisition in healthy older adults, though gastrointestinal side effects were reported.Human studies · Randomized controlled trial